BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1673123)

  • 1. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
    Salzman C; Solomon D; Miyawaki E; Glassman R; Rood L; Flowers E; Thayer S
    J Clin Psychiatry; 1991 Apr; 52(4):177-80. PubMed ID: 1673123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of benzodiazepines to control disruptive behavior in inpatients.
    Salzman C
    J Clin Psychiatry; 1988 Dec; 49 Suppl():13-5. PubMed ID: 3058683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.
    Bieniek SA; Ownby RL; Penalver A; Dominguez RA
    Pharmacotherapy; 1998; 18(1):57-62. PubMed ID: 9469682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.
    Dorevitch A; Katz N; Zemishlany Z; Aizenberg D; Weizman A
    Am J Psychiatry; 1999 Jan; 156(1):142-4. PubMed ID: 9892313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW; Simpson GM
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.
    Battaglia J; Moss S; Rush J; Kang J; Mendoza R; Leedom L; Dubin W; McGlynn C; Goodman L
    Am J Emerg Med; 1997 Jul; 15(4):335-40. PubMed ID: 9217519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.
    Garza-TreviƱo ES; Hollister LE; Overall JE; Alexander WF
    Am J Psychiatry; 1989 Dec; 146(12):1598-601. PubMed ID: 2686478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Resnick M; Burton BT
    J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.
    Harvey AT; Flockhart D; Gorski JC; Greenblatt DJ; Burke M; Werder S; Preskorn SH
    J Clin Pharmacol; 2004 Oct; 44(10):1173-84. PubMed ID: 15342619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid tranquillisation; review of the literature and recommendations].
    Bak M; van Os J; Marcelis M
    Tijdschr Psychiatr; 2011; 53(10):727-37. PubMed ID: 21989751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
    Veser FH; Veser BD; McMullan JT; Zealberg J; Currier GW
    J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
    Lejeune J; Larmo I; Chrzanowski W; Witte R; Karavatos A; Schreiner A; Lex A; Medori R
    Int Clin Psychopharmacol; 2004 Sep; 19(5):259-69. PubMed ID: 15289699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.
    Foster S; Kessel J; Berman ME; Simpson GM
    Int Clin Psychopharmacol; 1997 May; 12(3):175-9. PubMed ID: 9248875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
    Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
    JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
    J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.